RANI
Rani Therapeutics Holdings Inc Class A
North American company
Healthcare
Biotechnology
/
NAV Price
-
Last Traded
-
Chg
-
-
XNAS
-
Updated: -
Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. It has developed the RaniPill capsule, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.
NASDAQ:RANI
US7530181004
USD
Loading Comparison
Latest RANI News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News